Somavert 25 mg lyophilized powder for injection Images
Generic Name: pegvisomant
This medication has been identified as Somavert 25 mg lyophilized powder for injection. It is supplied by Pfizer Inc.
Somavert is used in the treatment of Acromegaly and belongs to the drug class growth hormone receptor blockers. There is no proven risk in humans during pregnancy. Somavert 25 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Somavert
- Generic Name
- pegvisomant
- Strength
- 25 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Growth hormone receptor blockers
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00009-5201
More about Somavert (pegvisomant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: growth hormone receptor blockers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.